IMMUNOAFFINITY PURIFICATION WITH ANTI-ID ANTIBODIES

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$49,979.00
Award Year:
1990
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Agency Tracking Number:
13735
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Viro Dynamics
129 E 92nd St, New York, NY, 10128
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Carl V Hamby
(914) 993-4195
Business Contact:
() -
Research Institution:
n/a
Abstract
ONE OF THE PRIMARY LIMITATIONS IN THE USE OF RADIOIMMUNOSCINTIGRAPHIC TECHNIQUES TO DETECT TUMORS CLINICALLY HAS BEEN THE DIFFICULTY IN ACHIEVING HIGH TUMOR-TO-NORMAL-TISSUE RATIOS OF BOUND RADIOACTIVITY. PART OF THIS DIFFICULTY ARISES FROM THE FACT THAT A SIGNIFICANT PROPORTION OF MONOCLONAL ANTIBODIES (MABS) ARE INACTIVATED DURING RADIOLABELING PROCEDURES AND SUCH MABS, WHEN INJECTEDINTRAVENOUSLY, LOCALIZE NONSPECIFICALLY IN NORMAL TISSUES. THIS PROJECT ADDRESSES THE PROBLEM THROUGH THE DEVELOPMENT OF AN INNOVATIVE METHOD FOR EFFECTIVELY SEPARATING ANTIBODIES DAMAGED DURING RADIOLABELING PROCEDURES FROM THOSE RETAINING THEIR ORIGINAL AFFINITY AND SPECIFICITY. PRELIMINARY STUDIES INDICATE THAT ANTI-IDIOTYPIC (ANTI-ID) MABS RECOGNIZING THE COMBINING SITES OF ANTIMELANOMA MABS CAN BE PREPARED AS AFFINITY MATRICES TO PURIFY THE ANTIMELANOMA MABS AFTER RADIOLABELING PROCEDURES. THE IMMUNOREACTIVITY, SPECIFICITY, AFFINITY, AND TUMOR-TO-TISSUE RATIOS OF IN-111-LABELED ANTIMELANOMA MABS WILL BE ASSAYED BEFORE AND AFTER IMMUNOAFFINITY PURIFICATION WITH ANTI-ID MABS. IF THE METHOD IS EFFECTIVE,IT MAY BE POSSIBLE TO INCREASE THE SENSITIVITY OF TUMOR DETECTION BY RADIOIMMUNOSCINTIGRAPHY.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government